Trade HRTX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Heron Therapeutics, Inc. (HRTX) is trading at US$0.32, down 2.11% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$60.41M. Over the past 52 weeks, HRTX has traded between US$0.30 and US$1.58. On Syfe you can trade HRTX with $0 commission and add it to your watchlist.
| Previous close | US$0.32 |
|---|---|
| Market cap | US$60.41M |
| 52-week range | US$0.30 – US$1.58 |
| Volume | 1.37M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Heron Therapeutics, Inc.
Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in Cary, NC.
Year: 1987
--HC Wainwright Downgrades Heron Therapeutics to Neutral From Buy
Aug 11, 11:30 AM · MT Newswires
Heron Therapeutics Receives Nasdaq Minimum Bid Price Notification
Jun 26, 10:16 AM · MT Newswires
--Needham Downgrades Heron Therapeutics to Hold From Buy
Jun 3, 11:28 AM · MT Newswires
Sector Update: Healthcare Stocks Softer Late Afternoon
Jun 2, 7:45 PM · MT Newswires
Sector Update: Healthcare Stocks Fall in Afternoon Trading
Jun 2, 5:54 PM · MT Newswires
Heron Therapeutics, Inc. (HRTX) stock is trading at US$0.32, -2.11% from the previous close of US$0.32.
The market cap for Heron Therapeutics, Inc. (HRTX) stock is approximately US$60.41M.
The 52-week high for Heron Therapeutics, Inc. (HRTX) stock is US$1.58.
The 52-week low for Heron Therapeutics, Inc. (HRTX) stock is US$0.30.
Heron Therapeutics, Inc. (HRTX) does not currently pay a dividend.
Stay on top of HRTX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
